Metilprednizolon Teva

Methylprednisolone, the active ingredient in Metilprednizolon Teva, is a corticosteroid presented as an injectable formulation for intravenous use. It reduces inflammation and modulates immune responses in acute and chronic inflammatory conditions.

GNH USA supplies Metilprednizolon Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Methylprednisolone is a glucocorticoid used to treat inflammatory and immune‑mediated conditions.

- Acute severe asthma exacerbations: rapid reduction of airway inflammation and bronchospasm. - Anaphylactic reactions: suppresses systemic allergic response and prevents progression. - Multiple sclerosis relapses: decreases central nervous system inflammation to improve neurological function. - Rheumatoid arthritis flares: lowers joint inflammation and pain. - Organ transplant rejection prophylaxis: inhibits immune activation to protect graft function.

Methylprednisolone may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Elevated blood glucose: hyperglycemia, especially in diabetic patients. - Fluid retention: edema and weight gain. - Mood changes: anxiety, insomnia, or euphoria. - Gastrointestinal discomfort: nausea, dyspepsia, or ulcer risk. - Increased susceptibility to infection: mild upper respiratory infections.

Serious or Rare Side Effects: - Adrenal suppression: risk of adrenal crisis on abrupt discontinuation. - Severe infections: opportunistic or reactivated infections. - Osteonecrosis: bone tissue death, particularly in weight‑bearing joints. - Psychiatric disturbances: psychosis or severe depression. - Cardiovascular events: hypertension or arrhythmias.

Before initiating therapy, consider patient‑specific risk factors and monitor appropriately.

- Screen for infections: assess and treat active infections before use. - Monitor blood glucose: especially in diabetic or pre‑diabetic patients. - Evaluate bone health: consider calcium/vitamin D supplementation for long‑term use. - Assess psychiatric history: watch for mood or behavioral changes. - Use lowest effective dose: limit duration to reduce systemic exposure. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Methylprednisolone can alter the activity of several concomitant medicines.

Major Interactions (Avoid): - Live vaccines: increased risk of disseminated infection. - Strong CYP3A4 inducers (e.g., rifampin, phenytoin): may reduce corticosteroid efficacy. - Anticoagulants (e.g., warfarin): heightened bleeding risk due to platelet effects.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory drugs (NSAIDs): additive gastrointestinal ulcer risk. - Diabetic agents: may require dose adjustment for hyperglycemia. - Antihypertensives: possible reduction in blood pressure control.